GLP-1 medications have transformed the conversation around weight management. Drugs such as semaglutide and tirzepatide have demonstrated remarkable results in large clinical trials, with many individuals achieving significant weight reduction alongside improvements in metabolic health. Yet in real life, the experience of these medications is rarely identical from one person to … [Read more...] about Why Two People Taking the Same GLP-1 Medication Can Experience Different Results
Weight Loss and Hormones: PCOS, Perimenopause and Beyond
For many women, weight loss begins to feel noticeably different somewhere in the mid-thirties. Strategies that once worked effortlessly suddenly feel ineffective, and weight may accumulate around the abdomen despite consistent efforts with diet and exercise. This shift is rarely about willpower or motivation. Instead, it reflects a complex interaction between hormones, … [Read more...] about Weight Loss and Hormones: PCOS, Perimenopause and Beyond
Medical Weight Loss for Women Over 35: A Hormonal and Metabolic Perspective
For many women, turning 35 marks a subtle but undeniable shift. The same nutrition plan that once worked effortlessly now feels ineffective. Exercise requires more recovery time. Sleep disturbances appear unexpectedly. Weight gain, particularly around the abdomen, becomes more persistent. These changes are not imagined, and they are not a reflection of diminished willpower. … [Read more...] about Medical Weight Loss for Women Over 35: A Hormonal and Metabolic Perspective
The Transition Phase: Moving from Weight Loss to Medical Stability
Weight loss is often portrayed as the finish line. The number on the scale drops, clothes fit differently, laboratory values improve, and confidence rises. Yet biologically, weight loss is not the end of the story. It is a powerful physiological disruption. The real milestone is not simply achieving a lower weight, but stabilising the body in its new metabolic state. This … [Read more...] about The Transition Phase: Moving from Weight Loss to Medical Stability
Alcohol and GLP-1 Medications: What You Should Know
GLP-1 receptor agonists have reshaped the landscape of weight management and metabolic care. Medications such as Wegovy and Mounjaro are increasingly used not only for weight reduction but also for improving insulin sensitivity, stabilising blood glucose, and reducing cardiometabolic risk. As their use becomes more widespread, a common and important question arises: what … [Read more...] about Alcohol and GLP-1 Medications: What You Should Know




